ÂÜÀòÂÒÂ×

Xijia W. currently serves as a Senior Research Associate at Tessera Therapeutics, where responsibilities include supporting the development of novel gene editors and conducting proof-of-concept studies involving cancer and primary cell lines. Previously, Xijia W. worked as a Research Associate at AGTC, contributing to a pre-clinical gene therapy project aimed at developing precision treatments for ALS and optimizing HSV-based AAV production. Xijia W. holds a Bachelor's degree in Biotechnology from Sun Yat-sen University and a Master of Engineering in Bioengineering and Biomedical Engineering from Cornell University, and is currently pursuing a Master's degree in Regulatory Affairs at Northeastern University.